BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3312023)

  • 21. Cystic fibrosis: intravenous treatment at home.
    Catchpole A
    Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotic treatment of cystic fibrosis exacerbations].
    Dumcius S
    Medicina (Kaunas); 2003; 39(3):221-4. PubMed ID: 12695633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions to piperacillin in adults with cystic fibrosis.
    Stead RJ; Kennedy HG; Hodson ME; Batten JC
    Thorax; 1985 Mar; 40(3):184-6. PubMed ID: 3983886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial therapy in cystic fibrosis.
    Mouton JW; Kerrebijn KF
    Med Clin North Am; 1990 May; 74(3):837-50. PubMed ID: 2186247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gentamicin as gene therapy.
    Luft FC
    J Mol Med (Berl); 2002 Sep; 80(9):543-4. PubMed ID: 12226735
    [No Abstract]   [Full Text] [Related]  

  • 27. Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis.
    Winter RJ; George RJ; Deacock SJ; Shee CD; Geddes DM
    Lancet; 1984 Jun; 1(8390):1338-9. PubMed ID: 6145035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H; Bergan T
    Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach.
    Marks MI
    Antibiot Chemother (1971); 1989; 42():229-36. PubMed ID: 2688544
    [No Abstract]   [Full Text] [Related]  

  • 31. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
    Cullen RT; McCrae WM; Govan J; Raeburn JA; Ingram TM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():369-75. PubMed ID: 6352647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa.
    Farinde A
    Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292
    [No Abstract]   [Full Text] [Related]  

  • 33. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Kerrebijn KF; Mouton J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of aerosolized antibiotics in patients with cystic fibrosis.
    Campbell PW; Saiman L
    Chest; 1999 Sep; 116(3):775-88. PubMed ID: 10492286
    [No Abstract]   [Full Text] [Related]  

  • 35. Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis.
    Fitzpatrick SB; Rosenstein BJ
    Clin Pediatr (Phila); 1983 Sep; 22(9):628-30. PubMed ID: 6224623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipseudomonal antibiotics and cystic fibrosis.
    Henry RL
    Aust N Z J Med; 1999 Feb; 29(1):5-7. PubMed ID: 10200806
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of antibiotics in cystic fibrosis. The Danish approach.
    Jensen T; Pedersen SS; Høiby N; Koch C; Flensborg EW
    Antibiot Chemother (1971); 1989; 42():237-46. PubMed ID: 2688545
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence for using nebulised antibiotics in cystic fibrosis.
    Conway SP
    Arch Dis Child; 1999 Apr; 80(4):307-9. PubMed ID: 10086931
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.
    Ciofu O; Tolker-Nielsen T; Jensen PØ; Wang H; Høiby N
    Adv Drug Deliv Rev; 2015 May; 85():7-23. PubMed ID: 25477303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patients.
    Paull A; Morgan JR
    J Antimicrob Chemother; 1986 Nov; 18(5):635-9. PubMed ID: 3100487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.